The drug UDCA (ursodeoxycholic acid) is largely prescribed to treat hepatobiliary disorders. This bile acid presents also intesreting anticancer properties, highlighted in a new publication from Oncowitan.

Goossens, J-F and Bailly, C. Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy, Pharmacology & Therapeutics (2019)

Read: https://doi.org/10.1016/j.pharmthera.2019.107396

Categories: News-Publications